loadpatents
name:-0.037682056427002
name:-0.030121803283691
name:-0.00057196617126465
Middleton; Steven A. Patent Filings

Middleton; Steven A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Middleton; Steven A..The latest application filed is for "substituted pyrimidinyl oxime kinase inhibitors".

Company Profile
0.25.29
  • Middleton; Steven A. - Flemington NJ US
  • Middleton; Steven A. - Cicero IN
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Hydroxy alkyl substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disorders
Grant 8,778,956 - Battista , et al. July 15, 2
2014-07-15
Substituted pyrimidinyl oxime kinase inhibitors
Grant 8,367,825 - Guozhang , et al. February 5, 2
2013-02-05
Bicyclic pyrimidine kinase inhibitors
Grant 8,314,234 - Connolly , et al. November 20, 2
2012-11-20
1,2,4-triazolylaminoaryl (heteroaryl) sulfonamide derivatives
Grant 8,299,082 - Huang , et al. October 30, 2
2012-10-30
Substituted Pyrimidinyl Oxime Kinase Inhibitors
App 20120157412 - Battista; Kathleen A. ;   et al.
2012-06-21
Substituted pyrimidinyl oxime kinase inhibitors
Grant 8,153,791 - Xu , et al. April 10, 2
2012-04-10
1,2,4-triazolylaminoaryl (heteroaryl) Sulfonamide Derivatives
App 20110077249 - Huang; Shenlin ;   et al.
2011-03-31
1,2,4-Triazolylaminoaryl (heteroaryl) sulfonamide derivatives
Grant 7,888,380 - Huang , et al. February 15, 2
2011-02-15
Pyrimidinyl substituted fused-pyrrolyl compounds useful in treating kinase disorders
Grant 7,855,205 - Huang , et al. December 21, 2
2010-12-21
Thiazolopyridine kinase inhibitors
Grant 7,659,284 - Connolly , et al. February 9, 2
2010-02-09
3-spirocyclic indolyl derivatives useful as ORL-1 receptor modulators
Grant 7,655,670 - Battista , et al. February 2, 2
2010-02-02
Substituted Thiazolo [4,5-d]pyrimidines as protein kinase inhibitors
Grant 7,605,154 - Binnun , et al. October 20, 2
2009-10-20
Hydroxy alkyl substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disorders
Grant 7,582,649 - Battista , et al. September 1, 2
2009-09-01
3-benzoimidazolyl-pyrazolopyridines useful in treating kinase disorders
Grant 7,541,367 - Chiu , et al. June 2, 2
2009-06-02
Hydroxy Alkyl Substituted 1,3,8-triazaspiro[4.5]decan-4-one Derivatives Useful For The Treatment Of Orl-1 Receptor Mediated Disorders
App 20090124614 - BATTISTA; Kathleen ;   et al.
2009-05-14
Substituted [4-(4-phenyl-piperazin-1-yl)-cyclohexyl]-urea compounds
Grant 7,517,885 - Chiu , et al. April 14, 2
2009-04-14
Bicyclic Pyrimidine Kinase Inhibitors
App 20090076037 - Connolly; Peter J. ;   et al.
2009-03-19
3-benzoimidazolyl-pyrazolopyridines useful in treating kinase disorders
App 20090048249 - Chiu; George ;   et al.
2009-02-19
Piperazinyl substituted cyclohexane-1,4-diamines
Grant 7,482,348 - Chiu , et al. January 27, 2
2009-01-27
Piperidinyl substituted cyclohexane-1,4-diamines
Grant 7,470,711 - Chiu , et al. December 30, 2
2008-12-30
Substituted Thiatriazaacenaphthylene-6-carbonitrile Kinase Inhibitors
App 20080300264 - Connolly; Peter J. ;   et al.
2008-12-04
Substituted isoindole-1,3-diones
Grant 7,459,557 - Chiu , et al. December 2, 2
2008-12-02
Substituted thiatriazaacenaphthylene-6-carbonitrile kinase inhibitors
Grant 7,427,625 - Connolly , et al. September 23, 2
2008-09-23
Substituted Thienopyrimidine Kinase Inhibitors
App 20080108611 - Battista; Kathleen A. ;   et al.
2008-05-08
3-piperidin-4-yl-indole Orl-1 Receptor Modulators
App 20080015214 - Bignan; Gilles C. ;   et al.
2008-01-17
Electronic assembly and manufacturing method having a reduced need for wire bonds
App 20080012099 - Yeh; Shing ;   et al.
2008-01-17
Substituted triazole diamine derivatives as kinase inhibitors
Grant 7,317,031 - Lin , et al. January 8, 2
2008-01-08
Substituted Pyrimidinyl Oxime Kinase Inhibitors
App 20070270425 - Xu; Guozhang ;   et al.
2007-11-22
Substituted Thiatriazaacenaphthylene-6-carbonitrile Kinase Inhibitors
App 20070225309 - Connolly; Peter J. ;   et al.
2007-09-27
Thiazolopyrimidine kinase inhibitors
App 20070185139 - Binnun; Eva ;   et al.
2007-08-09
Substituted [4-(4-phenyl-piperazin-1-yl)-cyclohexyl]-urea compounds
App 20070123542 - Chiu; George ;   et al.
2007-05-31
Novel 3-spirocyclic indolyl derivatives useful as ORL-1 receptor modulators
App 20070112016 - Battista; Kathleen A. ;   et al.
2007-05-17
Substituted isoindole-1,3-diones
App 20070093500 - Chiu; George ;   et al.
2007-04-26
Electronic assembly with controlled solder joint thickness
App 20060255476 - Kuhlman; Frederick F. ;   et al.
2006-11-16
Piperazinyl substituted cyclohexane-1,4-diamines
App 20060223825 - Chiu; George ;   et al.
2006-10-05
Piperidinyl substituted cyclohexane-1,4-diamines
App 20060217419 - Chiu; George ;   et al.
2006-09-28
Amino substituted pyridinyl methanone compounds useful in treating kinase disorders
Grant 7,109,220 - Lin , et al. September 19, 2
2006-09-19
Pyrimidinyl substituted fused-pyrrolyl compounds useful in treating kinase disorders
App 20060183900 - Huang; Shenlin ;   et al.
2006-08-17
Dihydroindolyl methanones as alpha 1a/1d adrenoreceptor modulators for the treatment of benign prostatic hypertrophy and lower urinary tract symptoms
App 20060183902 - Baxter; Ellen W. ;   et al.
2006-08-17
Cyclohexyldiamines as selective alpha 1a/1d adrenoreceptor antagonists for the treatment of benign prostatic hypertrophy and lower urinary tract symptoms
App 20060173015 - Chiu; George ;   et al.
2006-08-03
1,2,4-Triazolylaminoaryl (heteroaryl) sulfonamide derivatives
App 20060173020 - Huang; Shenlin ;   et al.
2006-08-03
Hydroxy alkyl substituted 1,3,8-Triazaspiro[4.5]decan-4-one derivatives useful for the treatment of orl-1receptor mediated disorders
Grant 7,081,463 - Battista , et al. July 25, 2
2006-07-25
Thiazolopyridine kinase inhibitors
App 20060058341 - Connolly; Peter J. ;   et al.
2006-03-16
Hydroxy alkyl substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disorders
App 20060030577 - Battista; Kathleen ;   et al.
2006-02-09
Pharmacophores for nociceptin, methods of obtaining and using in screening for nociceptin mimics
App 20050266575 - Mayo, Kevin H. ;   et al.
2005-12-01
Substituted triazole diamine derivatives as kinase inhibitors
App 20050182116 - Lin, Ronghui ;   et al.
2005-08-18
Substituted triazole diamine derivatives as kinase inhibitors
Grant 6,924,302 - Lin , et al. August 2, 2
2005-08-02
Amino substituted pyridinyl methanone compounds useful in treating kinase disorders
App 20050124610 - Lin, Ronghui ;   et al.
2005-06-09
Electronic module
App 20050104190 - Mithal, Pankaj ;   et al.
2005-05-19
Electronic module
Grant 6,809,423 - Mithal , et al. October 26, 2
2004-10-26
Hydroxy alkyl substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of ORL-1receptor mediated disorders
App 20040142955 - Battista, Kathleen ;   et al.
2004-07-22
Method for wire bonding an aluminum wire to a lead of an electronics package
Grant 5,492,263 - Webster , et al. February 20, 1
1996-02-20
Company Registrations

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed